Precision Medicines Targeting the
Regulatory Genome

We are leveraging the power of the human genome’s dark matter to develop precise and potent RNA therapies for reprogramming disease driving cell-states.

Learn more
We are hiring!
Latest News

HAYA Therapeutics Raises $65 Million in Series A Funding to Deliver Precision RNA-Guided Medicines for Chronic and Age-Related Diseases

Latest News

HAYA Therapeutics Raises $65 Million in Series A Funding to Deliver Precision RNA-Guided Medicines for Chronic and Age-Related Diseases

Latest News

HAYA Therapeutics Raises $65 Million in Series A Funding to Deliver Precision RNA-Guided Medicines for Chronic and Age-Related Diseases

Latest News

HAYA Therapeutics Raises $65 Million in Series A Funding to Deliver Precision RNA-Guided Medicines for Chronic and Age-Related Diseases

Coming soon

Exciting website updates are on the way. Stay tuned!

Dark Genome Graphic
Dark Genome graphic
Dark Genome graphicDark Genome Over RNA graphic

Our mission is to identify and address the RIGHT...

Accelerating the development of the next-generation of dark genome targets and therapeutics for underserved rare and chronic diseases.

Learn more

Target

Dark Genome derived regulatory RNAs

Learn more

Place

Diseased tissues & cells identified with proprietary tools & methods

Learn more

Time

Targeting lncRNAs processes & integration of environmental signals when modulating the epigenome

Learn more

Way

Emerging RNA-targeting modalities, such as modified antisense oligonucleotides (ASOs), to target and inhibit proprietary lncRNAs to prevent and reverse disease

Learn more

Supporters & Awards

A short list of our supporters and awards